The Potential Impact of GLP-1s on Your Population

April 3, 2025

SHARE IT :

There's no denying that GLP-1 medications are driving significant increases in pharmacy costs, prompting healthcare organizations to develop strategies that balance immediate financial pressures with the long-term benefits of reducing obesity-related conditions such as cardiovascular disease and diabetes.

Using Certilytics AI-driven predictive insights, take a look at the insights we're uncovering:
- Which drugs are driving up costs?
- What are the top chronic conditions impacting GLP-1 users?
- What are the side effects of GLP-1s?
- Are there members without Type 2 Diabetes, but who are obese taking GLP-1s?